Germany
Japan
United Kingdom
China
Recombinant Anti-CD98 (Clone RL388)
| Applications | FC, IP |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Antibodies
View as table DownloadRecombinant Anti-CD155 (Clone 3F1)
| Applications | ELISA, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-IL2R beta (Clone 5H4)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-TLR2 (Clone TL2.1)
| Applications | Bl, FC, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD115/M-CSFR (Clone AFS98)
| Applications | Bl, FC, IHC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD23 (Clone CAT-13.9C1)
| Applications | IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD53 (Clone 161-2 (53/2))
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone EDU-2 (B486))
| Applications | FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-C5aR (Clone S5/1)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Ferret, Human, Rabbit, Cow |
| Conjugation | Unconjugated |
Recombinant Anti-CCR5 (Clone T21/8)
| Applications | ELISA, FC, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CCR9 (Clone 9B1)
| Applications | FC, Neutralize |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CCR7 (Clone 4B12)
| Applications | FC, IP |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone FGK45)
| Applications | FC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-H4 K8Ac; K12Ac; K16Ac (Clone KM-2)
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone chi220)
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-EpCAM (Clone KS1/4)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD33 (Clone M195)
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD18 (Clone 60.3)
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD123 (Clone 7G3)
| Applications | FC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Category
-
Antibodies
- Primary Antibodies
Isotypes
- IgG2a, kappa
Clonalities
- Monoclonal
Filter by
Target Symbol
- CD3E (3)
- CD40LG (3)
- EBI3 (3)
- AHSA1 (2)
- AIM2 (2)
- BIRC5 (2)
- CCRL2 (2)
- CD33 (2)
- CD40 (2)
- EGFR (2)
- F (2)
- FITC (2)
- HSPA8 (2)
- ITGA2B (2)
- ITGB2 (2)
- ITGB7 (2)
- KRT1 (2)
- LAG3 (2)
- LY6G (2)
- MS4A1 (2)
- MUC1 (2)
- PTPRC (2)
- TCP1 (2)
- TLR2 (2)
- TNF (2)
- TP53 (2)
- UBB (2)
- ACP5 (1)
- ALPP (1)
- AOC3 (1)
- APOA1 (1)
- APP (1)
- ATP1B1 (1)
- C5AR1 (1)
- CALB1 (1)
- CASP3 (1)
- CCR4 (1)
- CCR5 (1)
- CCR7 (1)
- CCR9 (1)
- CD19 (1)
- CD27 (1)
- CD274 (1)
- CD37 (1)
- CD4 (1)
- CD44 (1)
- CD47 (1)
- CD53 (1)
- CD70 (1)
- CD79A (1)
- CD8 (1)
- CD80 (1)
- CD8A (1)
- CDH16 (1)
- CDK1 (1)
- CLDN7 (1)
- CMKLR1 (1)
- COX15 (1)
- CR1 (1)
- CSF1R (1)
- DCX (1)
- EIF3I (1)
- ENG (1)
- EPCAM (1)
- ERBB2 (1)
- FBXW7 (1)
- FCER2 (1)
- FOLR2 (1)
- GCSAM (1)
- GROUP ANTIGEN (1)
- H4 (1)
- HAVCR1 (1)
- HGF (1)
- HIST3H3 (1)
- HJV (1)
- HSPA4 (1)
- HSPA5 (1)
- ICOSL (1)
- IFNGR1 (1)
- IGF2R (1)
- IL16 (1)
- IL17A (1)
- IL2RB (1)
- IL3RA (1)
- IL5 (1)
- IL7R (1)
- IL9R (1)
- INSR (1)
- ITGA5 (1)
- ITGAL (1)
- ITGB1 (1)
- KRT15 (1)
- KRT20 (1)
- KRT5 (1)
- LGALS9 (1)
- LY75 (1)
- MDH2 (1)
- MHC I (1)
- MME (1)
- MUC6 (1)
Reactivities
Applications
Antibody Hosts
Conjugates
Modifications
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (11)
- This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (2)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (1)
- This reformatted antibody was made using the variable domain sequences of the original mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (38)
- Transmembrane (21)
- ES Cell Differentiation/IPS (10)
- Secreted Protein (9)
- Stem cell - Pluripotency (7)
- Transcription Factors (4)
- Adult stem cells (2)
- Protease (2)
- Protein Kinase (2)
- Stem cell relevant signaling - Wnt Signaling pathway (2)
- Cancer stem cells (1)
- Embryonic stem cells (1)
- Induced pluripotent stem cells (1)
- Phosphatase (1)
- Stem cell relevant signaling - DSL/Notch pathway (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
Pathways
- Pathways in cancer (8)
- Colorectal cancer (5)
- MAPK signaling pathway (5)
- Antigen processing and presentation (4)
- Basal cell carcinoma (3)
- Cell cycle (3)
- Hematopoietic cell lineage (3)
- Metabolic pathways (3)
- Parkinson's disease (3)
- Toll-like receptor signaling pathway (3)
- Wnt signaling pathway (3)
- p53 signaling pathway (3)
- Amyotrophic lateral sclerosis (ALS) (2)
- Apoptosis (2)
- Bladder cancer (2)
- Cell adhesion molecules (CAMs) (2)
- Chronic myeloid leukemia (2)
- Cytokine-cytokine receptor interaction (2)
- Cytosolic DNA-sensing pathway (2)
- Endocytosis (2)
- Endometrial cancer (2)
- Fc gamma R-mediated phagocytosis (2)
- Focal adhesion (2)
- Hedgehog signaling pathway (2)
- Huntington's disease (2)
- Melanoma (2)
- Natural killer cell mediated cytotoxicity (2)
- Pathogenic Escherichia coli infection (2)
- Small cell lung cancer (2)
- Spliceosome (2)
- Thyroid cancer (2)
- Acute myeloid leukemia (1)
- Alzheimer's disease (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- B cell receptor signaling pathway (1)
- Cardiac muscle contraction (1)
- Citrate cycle (TCA cycle) (1)
- Dilated cardiomyopathy (1)
- ECM-receptor interaction (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- ErbB signaling pathway (1)
- Fc epsilon RI signaling pathway (1)
- Folate biosynthesis (1)
- Gap junction (1)
- Glioma (1)
- Glyoxylate and dicarboxylate metabolism (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Jak-STAT signaling pathway (1)
- Leukocyte transendothelial migration (1)
- Lysosome (1)
- Melanogenesis (1)
- Neurotrophin signaling pathway (1)
- Non-small cell lung cancer (1)
- Oocyte meiosis (1)
- Oxidative phosphorylation (1)
- PPAR signaling pathway (1)
- Pancreatic cancer (1)
- Porphyrin and chlorophyll metabolism (1)
- Primary immunodeficiency (1)
- Prion diseases (1)
- Progesterone-mediated oocyte maturation (1)
- Prostate cancer (1)
- Pyruvate metabolism (1)
- Regulation of actin cytoskeleton (1)
- Renal cell carcinoma (1)
- Systemic lupus erythematosus (1)
- T cell receptor signaling pathway (1)
- TGF-beta signaling pathway (1)
- Ubiquitin mediated proteolysis (1)
- Viral myocarditis (1)